Abstract
The discovery and use of antibacterials represents a primary success of modern pharmaceutical industry. However, the pace of antibacterial discovery was heavily hindered by a series of technical difficulties and the unfavorable economics in recent years. The past decade has witnessed rapid progresses in omics and systems biology, which provided an unprecedented opportunity to accelerate the discovery of antibacterials. In this article, we first summarize the successful use of metabolic network analysis in antibacterial discovery. Then, we reveal that metabolite concentration serves as a useful criterion for selecting antimicrobial targets. The essential enzymes with low substrate concentrations (< 0.5 mM) are more druggable antibacterial targets. Besides, we find that the solubility of clinically used competitive antibacterials is at least 100 times higher than the concentrations of the competed substrates. By the new-proposed criterion, we not only identify some promising antibacterial targets but also explain some perplexing experimental observations as well.
Keywords: Antibacterial discovery, antibacterial target, bioinformatics, flux balance analysis (FBA), metabolic network, metabolite concentration, metabolomics, systems biology.
Current Computer-Aided Drug Design
Title:Metabolite Concentration as a Criterion for Antibacterial Discovery
Volume: 9 Issue: 3
Author(s): Zhong-Yi Wang, Qiang Zhu and Hong-Yu Zhang
Affiliation:
Keywords: Antibacterial discovery, antibacterial target, bioinformatics, flux balance analysis (FBA), metabolic network, metabolite concentration, metabolomics, systems biology.
Abstract: The discovery and use of antibacterials represents a primary success of modern pharmaceutical industry. However, the pace of antibacterial discovery was heavily hindered by a series of technical difficulties and the unfavorable economics in recent years. The past decade has witnessed rapid progresses in omics and systems biology, which provided an unprecedented opportunity to accelerate the discovery of antibacterials. In this article, we first summarize the successful use of metabolic network analysis in antibacterial discovery. Then, we reveal that metabolite concentration serves as a useful criterion for selecting antimicrobial targets. The essential enzymes with low substrate concentrations (< 0.5 mM) are more druggable antibacterial targets. Besides, we find that the solubility of clinically used competitive antibacterials is at least 100 times higher than the concentrations of the competed substrates. By the new-proposed criterion, we not only identify some promising antibacterial targets but also explain some perplexing experimental observations as well.
Export Options
About this article
Cite this article as:
Wang Zhong-Yi, Zhu Qiang and Zhang Hong-Yu, Metabolite Concentration as a Criterion for Antibacterial Discovery, Current Computer-Aided Drug Design 2013; 9 (3) . https://dx.doi.org/10.2174/15734099113099990030
DOI https://dx.doi.org/10.2174/15734099113099990030 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Beneficial Effects of QIAPI 1<sup>®</sup> against Pentavalent Arsenic-Induced
Lung Toxicity: A Hypothetical Model for SARS CoV2-I nduced Lung
Toxicity
Current Pharmaceutical Biotechnology Microwave Assisted Preparation of New Dicoumarinyl Pyrazoline Derivatives as Antimicrobials
Current Microwave Chemistry Antibacterial Effects of Carbon Monoxide
Current Pharmaceutical Biotechnology Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery The Chemical Composition and Anti-mycobacterial Activities of <i>Trachyspermum copticum</i> and <i>Pelargonium graveolens</i> Essential Oils
Recent Patents on Anti-Infective Drug Discovery Results of a Community-Based Antiretroviral Treatment Program for HIV-1 Infection in Western Uganda
Current HIV Research On the Contribution of Molecular Topology to Drug Design and Discovery
Current Computer-Aided Drug Design Editorial (Thematic Issue: Iron Chelation and Drug Resistance in Cancer and Tuberculosis)
Current Pharmaceutical Biotechnology Pleiotropic Regulatory Genes as A Tool for <i>Streptomyces</i> Strains Bioprospecting and Improvement
Current Biotechnology Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Mass Spectrometry in the Elucidation of the Glycoproteome of Bacterial Pathogens
Current Proteomics Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Editorial (Thematic Issue: Tropical Rheumatology)
Current Rheumatology Reviews Matrix Metalloproteinases in Respiratory Diseases: From Pathogenesis to Potential Clinical Implications
Current Medicinal Chemistry Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer
Current Pharmaceutical Design DNA-Electrochemical Biosensors: AFM Surface Characterisation and Application to Detection of In Situ Oxidative Damage to DNA
Combinatorial Chemistry & High Throughput Screening A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
Coronaviruses